聚合物配方的神经生长因子显示了对脑微发作的有效治疗效果
Lingli Yan1, Kunyao Xu2, Chaoyong Liu2
1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, 999078, China.
Advanced materials (Deerfield Beach, Fla.)
|November 27, 2024
概括
一种新的神经生长因子治疗有效地减少了大脑微型心脏病发作,并改善了小鼠的认知功能. 这一突破为治疗痴呆症和其他神经退行性疾病提供了希望.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 大脑微发作在老年痴呆症,阿尔茨海默病和血管风险因素患者中很常见.
- 目前还没有有效的治疗大脑微心脏病发作.
- 这些微型心脏病发作有助于认知能力下降和神经退行.
研究的目的:
- 为了研究一种新型的聚合物配方的神经生长因子 (NGF),用于治疗大脑微型心脏病发作.
- 在小鼠模型中评估穿透血脑屏障的NGF的疗效.
主要方法:
- 用于穿越血脑屏障的聚合物配方NGF的管理.
- 评估氧化应激标志物和神经元亡.
- 分析心脏病发作部位的微质极化.
- 微心脏病发作负担的量化.
- 在小鼠模型中评估行为和认知功能.
主要成果:
- 新型NGF治疗显著降低了氧化应激和神经元亡.
- 在心脏病发作部位的微质两极分化被有效地重塑为一个支持解决的表型.
- 观察到大脑微发作总体负担的减少.
- 在接受治疗的小鼠中,行为和认知功能显著改善.
结论:
- 聚合物配制的,穿透血脑屏障的NGF证明了对脑微发作的治疗潜力.
- 这种方法为治疗神经退行性疾病提供了一个有希望的新策略.
- 对基于NGF的治疗方法的进一步研究可以促进痴呆症和相关疾病的治疗.
相关概念视频
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Neurogenesis and Regeneration of Nervous Tissue
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...


